Barriers to care include patient embarrassment about their condition, lack of awareness that serious complications can result from mismanagement of incontinence, the perception that bladder issues are ...
Boston Scientific has acquired Valencia Technologies Corporation, a medtech company that focuses on developing and commercializing bladder dysfunction treatment solutions. The company’s flagship ...
News-Medical.Net on MSN
Blood biomarker guides bladder-sparing treatment decisions for cancer patients
Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence ...
Add Yahoo as a preferred source to see more of our stories on Google. Transplant recipient Oscar Larrainzar is flanked by UCLA's Dr. Nima Nassiri (L) and USC's Dr. Inderbir Gill as they walked down a ...
UConn Center on Aging researchers have published a new editorial in the journal Aging titled "Polyploidy-induced senescence: Linking development, differentiation, repair, and (possibly) cancer?" In ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
Researchers have successfully regenerated functional bladder tissue in a baboon using the animal’s own bone marrow cells. With the organ working within a few months and staying healthy throughout the ...
Noninvasive treatment options for NGB dysfunction include intermittent catheterization, Crede and Valsalva, indwelling catheterization, lifestyle changes/behavioral modification, and oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results